Bastasch, Michael <br/><br/>
Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lung--a Kansas Cancer Institute and Thompson Cancer Survival Center Study.  [electronic resource] 

 -  Investigational new drugs  Aug 2002 
 - 339-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1023/a:1016293527755  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines--administration & dosage<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Pyrazoles--administration & dosage<br/>Survival Analysis